[{"id":"f1bf7f47-5eb8-4967-88d5-00eb9911f656","acronym":"FAST","url":"https://clinicaltrials.gov/study/NCT05990426","created_at":"2023-11-13T16:14:40.904Z","updated_at":"2024-07-02T16:35:29.446Z","phase":"","brief_title":"Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy","source_id_and_acronym":"NCT05990426 - FAST","lead_sponsor":"Northwestern University","biomarkers":" IGF1 • IGFBP1","pipe":"","alterations":" ","tags":["IGF1 • IGFBP1"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/16/2023","start_date":" 10/16/2023","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 08/01/2026","study_completion_date":" 08/01/2026","last_update_posted":"2023-11-13"},{"id":"0a35d3c0-57af-4e09-9c05-bc2f2fae9bf5","acronym":"LungMaas","url":"https://clinicaltrials.gov/study/NCT05794529","created_at":"2023-04-03T15:03:26.250Z","updated_at":"2024-07-02T16:35:51.641Z","phase":"","brief_title":"Lung Tumor Protein Synthesis Rates in Lung Cancer Patients","source_id_and_acronym":"NCT05794529 - LungMaas","lead_sponsor":"Maastricht University Medical Center","biomarkers":" IL6 • TNFA • IGF1 • IL10 • IGFBP3 • IGFBP1","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGF1 • IL10 • IGFBP3 • IGFBP1"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 03/01/2023","start_date":" 03/01/2023","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 03/01/2026","study_completion_date":" 03/01/2026","last_update_posted":"2023-04-03"},{"id":"4440793a-ab83-4b82-b144-f3e5b46b6fe3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05748704","created_at":"2023-03-01T15:01:57.757Z","updated_at":"2024-07-02T16:35:54.508Z","phase":"Phase 1","brief_title":"Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients","source_id_and_acronym":"NCT05748704","lead_sponsor":"University of Genova","biomarkers":" CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP","pipe":"","alterations":" ","tags":["CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 11/01/2021","start_date":" 11/01/2021","primary_txt":" Primary completion: 11/01/2025","primary_completion_date":" 11/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2023-03-01"},{"id":"e2ba8f73-021f-4815-bd4f-48ebd4e397b8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02278965","created_at":"2021-01-18T10:43:45.075Z","updated_at":"2024-07-02T16:36:05.372Z","phase":"Phase 1","brief_title":"Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer","source_id_and_acronym":"NCT02278965","lead_sponsor":"Katherine D. Crew","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/22/2015","start_date":" 01/22/2015","primary_txt":" Primary completion: 04/19/2017","primary_completion_date":" 04/19/2017","study_txt":" Completion: 04/19/2017","study_completion_date":" 04/19/2017","last_update_posted":"2022-08-17"},{"id":"27701bbd-0531-4a28-a838-0f6fcfa68001","acronym":"","url":"https://clinicaltrials.gov/study/NCT01312467","created_at":"2021-01-18T05:20:31.906Z","updated_at":"2024-07-02T16:37:02.239Z","phase":"Phase 2a","brief_title":"Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI","source_id_and_acronym":"NCT01312467","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" IGF1 • IGFBP3 • IGFBP1 • LEP","pipe":"","alterations":" ","tags":["IGF1 • IGFBP3 • IGFBP1 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 45","initiation":"Initiation: 03/01/2011","start_date":" 03/01/2011","primary_txt":" Primary completion: 03/01/2014","primary_completion_date":" 03/01/2014","study_txt":" Completion: 12/01/2014","study_completion_date":" 12/01/2014","last_update_posted":"2019-03-05"},{"id":"b02bbce8-c9f2-468f-acdc-98a877b32fb5","acronym":"","url":"https://clinicaltrials.gov/study/NCT01762241","created_at":"2021-01-18T07:44:49.719Z","updated_at":"2024-07-02T16:37:02.330Z","phase":"","brief_title":"Xbox Kinect Training in Men With Prostate Cancer","source_id_and_acronym":"NCT01762241","lead_sponsor":"Hospitalsenheden Vest","biomarkers":" IGF1 • IGF2 • IGFBP1","pipe":"","alterations":" ","tags":["IGF1 • IGF2 • IGFBP1"],"overall_status":"Completed","enrollment":" Enrollment 46","initiation":"Initiation: 02/01/2015","start_date":" 02/01/2015","primary_txt":" Primary completion: 06/01/2018","primary_completion_date":" 06/01/2018","study_txt":" Completion: 06/01/2018","study_completion_date":" 06/01/2018","last_update_posted":"2019-03-01"},{"id":"1010dc9f-7521-4bc5-879d-97804f6e7e77","acronym":"","url":"https://clinicaltrials.gov/study/NCT00475982","created_at":"2021-01-18T01:41:50.639Z","updated_at":"2024-07-02T16:37:03.329Z","phase":"","brief_title":"Effect of Weight Loss on Prostate Cancer Pathology","source_id_and_acronym":"NCT00475982","lead_sponsor":"VA Office of Research and Development","biomarkers":" IGF1 • IGFBP1","pipe":"","alterations":" ","tags":["IGF1 • IGFBP1"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 01/01/2009","start_date":" 01/01/2009","primary_txt":" Primary completion: 03/01/2016","primary_completion_date":" 03/01/2016","study_txt":" Completion: 03/01/2016","study_completion_date":" 03/01/2016","last_update_posted":"2019-01-31"},{"id":"ec0850a6-945c-4516-98b9-daf70ac727f1","acronym":"EASE","url":"https://clinicaltrials.gov/study/NCT02179762","created_at":"2021-01-18T10:10:05.334Z","updated_at":"2024-07-02T16:37:08.076Z","phase":"","brief_title":"Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer","source_id_and_acronym":"NCT02179762 - EASE","lead_sponsor":"Case Comprehensive Cancer Center","biomarkers":" TNFA • IGF1 • IGFBP3 • IGFBP1 • LEP","pipe":"","alterations":" ","tags":["TNFA • IGF1 • IGFBP3 • IGFBP1 • LEP"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/09/2014","start_date":" 08/09/2014","primary_txt":" Primary completion: 07/23/2018","primary_completion_date":" 07/23/2018","study_txt":" Completion: 07/23/2018","study_completion_date":" 07/23/2018","last_update_posted":"2018-08-09"},{"id":"2971681e-4c6f-4c59-9941-ab8a3f93f501","acronym":"","url":"https://clinicaltrials.gov/study/NCT03171506","created_at":"2021-01-18T15:38:11.380Z","updated_at":"2024-07-02T16:37:19.025Z","phase":"","brief_title":"Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification","source_id_and_acronym":"NCT03171506","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" MUC16 • IGF1 • IGFBP1","pipe":" | ","alterations":" MUC16 elevation","tags":["MUC16 • IGF1 • IGFBP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MUC16 elevation"],"overall_status":"Completed","enrollment":" Enrollment 57","initiation":"Initiation: 11/09/2015","start_date":" 11/09/2015","primary_txt":" Primary completion: 07/18/2017","primary_completion_date":" 07/18/2017","study_txt":" Completion: 07/18/2017","study_completion_date":" 07/18/2017","last_update_posted":"2017-08-10"},{"id":"1b9e2dc5-5552-478c-92c4-182ad765fcfe","acronym":"ICOS","url":"https://clinicaltrials.gov/study/NCT02609373","created_at":"2021-01-18T12:40:34.163Z","updated_at":"2024-07-02T16:37:27.773Z","phase":"","brief_title":"Improving Cancer-Related Outcomes in Shift Workers","source_id_and_acronym":"NCT02609373 - ICOS","lead_sponsor":"University of British Columbia","biomarkers":" IGF1 • CRP • IGFBP1","pipe":"","alterations":" ","tags":["IGF1 • CRP • IGFBP1"],"overall_status":"Completed","enrollment":" Enrollment 47","initiation":"Initiation: 07/01/2011","start_date":" 07/01/2011","primary_txt":" Primary completion: 04/01/2015","primary_completion_date":" 04/01/2015","study_txt":" Completion: 01/01/2016","study_completion_date":" 01/01/2016","last_update_posted":"2016-11-03"},{"id":"fe483aa4-fb68-4ecb-afc4-66f383238c79","acronym":"","url":"https://clinicaltrials.gov/study/NCT02466061","created_at":"2021-01-18T11:52:10.923Z","updated_at":"2024-07-02T16:37:31.541Z","phase":"","brief_title":"TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors","source_id_and_acronym":"NCT02466061","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" IL6 • CXCL8 • IL2 • IL1B • IL7 • IGFBP1","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL2 • IL1B • IL7 • IGFBP1"],"overall_status":"Completed","enrollment":" Enrollment 207","initiation":"Initiation: 07/01/2014","start_date":" 07/01/2014","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 06/01/2016","study_completion_date":" 06/01/2016","last_update_posted":"2016-06-02"}]